Julie Clark
Director Técnico/Científico/I+D en OPTHEA LIMITED .
Cargos activos de Julie Clark
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OPTHEA LIMITED | Director Técnico/Científico/I+D | 01/02/2024 | - |
Historial de carrera de Julie Clark
Antiguos cargos conocidos de Julie Clark.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Director Técnico/Científico/I+D | - | 22/10/2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2011 | 01/10/2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Director Técnico/Científico/I+D | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formación de Julie Clark.
| Wake Forest School of Medicine | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| Wake Forest University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Australia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Empresas privadas | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Julie Clark
- Experiencia
